使用患者衍生异体细胞癌的血清蛋白生物标志物的鉴定
Dalin Zhang1, Chun-Lung Chiu1,2, Fernando Jose Garcia Marques3,4
1Department of Urology, Stanford University School of Medicine, Stanford, California, USA.
The Journal of clinical investigation
|January 2, 2026
概括
No abstract available in PubMed .
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.7K
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
14.1K
